What is the share price of Ngl Fine Chem Ltd (NGLFINE) today?
The share price of NGLFINE as on 13th June 2025 is ₹1050. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ngl Fine Chem Ltd (NGLFINE) share?
The past returns of Ngl Fine Chem Ltd (NGLFINE) share are- Past 1 week: -1.99%
- Past 1 month: -5.99%
- Past 3 months: -7.55%
- Past 6 months: -45.30%
- Past 1 year: -55.08%
- Past 3 years: N/A%
- Past 5 years: -43.82%
What are the peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE)?
The peers or stocks similar to Ngl Fine Chem Ltd (NGLFINE) include:What is the market cap of Ngl Fine Chem Ltd (NGLFINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ngl Fine Chem Ltd (NGLFINE) is ₹647.84 Cr as of 13th June 2025.What is the 52 week high and low of Ngl Fine Chem Ltd (NGLFINE) share?
The 52-week high of Ngl Fine Chem Ltd (NGLFINE) is ₹2777.95 and the 52-week low is ₹957.What is the PE and PB ratio of Ngl Fine Chem Ltd (NGLFINE) stock?
The P/E (price-to-earnings) ratio of Ngl Fine Chem Ltd (NGLFINE) is 30.66. The P/B (price-to-book) ratio is 2.47.Which sector does Ngl Fine Chem Ltd (NGLFINE) belong to?
Ngl Fine Chem Ltd (NGLFINE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ngl Fine Chem Ltd (NGLFINE) shares?
You can directly buy Ngl Fine Chem Ltd (NGLFINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ngl Fine Chem Ltd
NGLFINE Share Price
NGLFINE Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
NGLFINE Performance & Key Metrics
NGLFINE Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
31.06 | 2.47 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
36.21 | 6.66 | 0.83% |
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
NGLFINE Company Profile
NGL Fine-Chem Limited is manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health.
NGLFINE Forecast
NGLFINE Forecasts
Price
Revenue
Earnings
NGLFINE Company Revenue Forecast
NGLFINE Company Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
NGLFINE Stock EPS (Earnings Per Share) Forecast
NGLFINE Stock EPS (Earnings Per Share) Forecast
All values in ₹
All values in ₹
NGLFINE
NGLFINE
Income
Balance Sheet
Cash Flow
NGLFINE Income Statement
NGLFINE Income Statement
Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 157.29 | 154.74 | 265.99 | 328.18 | 283.61 | 352.82 | 376.89 | 378.22 | ||||||||
Raw Materials | 65.29 | 71.02 | 102.62 | 172.27 | 118.75 | 173.47 | 334.39 | 335.98 | ||||||||
Power & Fuel Cost | 8.71 | 9.99 | 9.85 | 15.86 | 18.53 | 23.25 | ||||||||||
Employee Cost | 21.16 | 24.04 | 28.09 | 34.85 | 36.87 | 45.12 | ||||||||||
Selling & Administrative Expenses | 10.22 | 8.00 | 11.62 | 8.69 | 11.55 | 14.90 | ||||||||||
Operating & Other expenses | 15.50 | 18.87 | 25.69 | 17.64 | 57.42 | 28.20 | ||||||||||
EBITDA | 36.41 | 22.82 | 88.12 | 78.87 | 40.49 | 67.88 | 42.50 | 42.24 | ||||||||
Depreciation/Amortization | 6.30 | 8.11 | 8.33 | 10.37 | 11.29 | 11.64 | 12.45 | 12.45 | ||||||||
PBIT | 30.11 | 14.71 | 79.79 | 68.50 | 29.20 | 56.24 | 30.05 | 29.79 | ||||||||
Interest & Other Items | 2.55 | 2.63 | 2.20 | 1.91 | 1.83 | 1.81 | 2.33 | 2.33 | ||||||||
PBT | 27.56 | 12.08 | 77.59 | 66.59 | 27.37 | 54.43 | 27.72 | 27.46 | ||||||||
Taxes & Other Items | 7.44 | 3.73 | 20.87 | 16.70 | 6.87 | 13.11 | 6.59 | 6.60 | ||||||||
Net Income | 20.12 | 8.35 | 56.72 | 49.89 | 20.50 | 41.32 | 21.13 | 20.86 | ||||||||
EPS | 32.57 | 13.52 | 91.81 | 80.75 | 33.18 | 66.88 | 34.19 | 33.76 | ||||||||
DPS | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 1.75 | 0.00 | 1.75 | ||||||||
Payout ratio | 0.05 | 0.13 | 0.02 | 0.02 | 0.05 | 0.03 | 0.00 | 0.05 |
NGLFINE Company Updates
Investor Presentation
NGLFINE Stock Peers
NGLFINE Past Performance & Peer Comparison
NGLFINE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ngl Fine Chem Ltd | 30.66 | 2.47 | — |
Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
Cipla Ltd | 23.03 | 4.53 | 1.06% |
Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
NGLFINE Stock Price Comparison
Compare NGLFINE with any stock or ETFNGLFINE Holdings
NGLFINE Shareholdings
NGLFINE Promoter Holdings Trend
NGLFINE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
NGLFINE Institutional Holdings Trend
NGLFINE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
NGLFINE Shareholding Pattern
NGLFINE Shareholding Pattern
NGLFINE Shareholding History
NGLFINE Shareholding History
Mutual Funds Invested in NGLFINE
Mutual Funds Invested in NGLFINE
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Ngl Fine Chem Ltd
Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 106/109 (-7) |
Compare 3-month MF holding change on Screener
smallcases containing NGLFINE stock
smallcases containing NGLFINE stock
Looks like this stock is not in any smallcase yet.
NGLFINE Events
NGLFINE Events
NGLFINE Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
NGLFINE Dividend Trend
No dividend trend available
NGLFINE Upcoming Dividends
NGLFINE Upcoming Dividends
No upcoming dividends are available
NGLFINE Past Dividends
NGLFINE Past Dividends
Cash Dividend
Ex DateEx DateAug 16, 2024
Dividend/Share
₹1.75
Ex DateEx Date
Aug 16, 2024
Cash Dividend
Ex DateEx DateAug 18, 2023
Dividend/Share
₹1.75
Ex DateEx Date
Aug 18, 2023
Cash Dividend
Ex DateEx DateJun 22, 2022
Dividend/Share
₹1.75
Ex DateEx Date
Jun 22, 2022
Cash Dividend
Ex DateEx DateAug 12, 2021
Dividend/Share
₹1.75
Ex DateEx Date
Aug 12, 2021
Cash Dividend
Ex DateEx DateAug 6, 2020
Dividend/Share
₹1.75
Ex DateEx Date
Aug 6, 2020
NGLFINE Stock News & Opinions
NGLFINE Stock News & Opinions
NGL Fine-Chem announced that the 44th Annual General Meeting(AGM) of the company will be held on 19 May 2025.Powered by Capital Market - Live
NGL Fine Chem has fixed 12 August 2025 as record date for payment of final dividend. The dividend will be paid on or after 26 August 2025. Powered by Capital Market - Live
NGL Fine-Chem announced that the Board of Directors of the Company at its meeting held on 22 May 2025, inter alia, have recommended the final dividend of Rs 1.75 per equity Share (i.e. 35%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Net profit of NGL Fine Chem declined 95.62% to Rs 0.54 crore in the quarter ended March 2025 as against Rs 12.32 crore during the previous quarter ended March 2024. Sales declined 4.80% to Rs 94.97 crore in the quarter ended March 2025 as against Rs 99.76 crore during the previous quarter ended March 2024. For the full year,net profit declined 48.89% to Rs 21.12 crore in the year ended March 2025 as against Rs 41.32 crore during the previous year ended March 2024. Sales rose 8.73% to Rs 368.26 crore in the year ended March 2025 as against Rs 338.69 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales94.9799.76 -5 368.26338.69 9 OPM %6.6515.86 -9.2015.73 - PBDT4.3819.01 -77 40.1766.06 -39 PBT1.0616.09 -93 27.7154.42 -49 NP0.5412.32 -96 21.1241.32 -49 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 22 May 2025.Powered by Capital Market - Live
The agency has also affirmed the company's short-term rating at '[ICRA] A2'. ICRA stated that the reaffirmation of ratings of NGL Fine-Chem (NGL) factors in the company's established operational track record, the extensive experience of its management in the animal health active pharmaceutical ingredients (API) segment, its diversified geographical presence in domestic and international markets and its well-established client base built over the years. Also, NGL continues to maintain a strong market share for its top three APIs (diminazene, clorsulon and buparvaquone), supported by a competitive cost proposition since it is partly backward integrated for basic chemicals. Going forward, topline growth is expected tobe supported by improvement in realisations, penetration in new geographies and expansion of itsproduct line. The ratings, however, remain constrained by the moderate scale of operations and high working capital intensity of NGL's business, stemming from receivables and an elevated inventory holding cycle. Also, the company's profitability remains vulnerable to volatility in raw material prices, as demonstrated in FY2023. Moreover, given the nature of short-term contracts, the company's operating profitability remains exposed to the movements in the raw materials prices that cannot be passed onto customers. NGL Fine-Chem is a veterinary API manufacturer and its products are used in the animal health care industry. NGL had acquired a 100% stake in Macrotech Polychem (MPPL) in May 2019. MPPL manufactures pharmaceutical intermediates and serves as the backward integrated unit for the company. The scrip had shed 0.10% to end at Rs 1089 on the BSE today. Powered by Capital Market - Live
Quadrant Future Tek Ltd, Banco Products (India) Ltd, Carraro India Ltd and Excel Industries Ltd are among the other losers in the BSE's 'B' group today, 10 February 2025.NGL Fine Chem Ltd tumbled 20.00% to Rs 1501.6 at 14:28 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 9273 shares were traded on the counter so far as against the average daily volumes of 831 shares in the past one month.Quadrant Future Tek Ltd crashed 20.00% to Rs 557.2. The stock was the second biggest loser in 'B' group.On the BSE, 2.78 lakh shares were traded on the counter so far as against the average daily volumes of 4.79 lakh shares in the past one month.Banco Products (India) Ltd lost 19.89% to Rs 369.4. The stock was the third biggest loser in 'B' group.On the BSE, 2.46 lakh shares were traded on the counter so far as against the average daily volumes of 22886 shares in the past one month.Carraro India Ltd plummeted 17.49% to Rs 357.95. The stock was the fourth biggest loser in 'B' group.On the BSE, 2.13 lakh shares were traded on the counter so far as against the average daily volumes of 21443 shares in the past one month.Excel Industries Ltd slipped 16.79% to Rs 1143. The stock was the fifth biggest loser in 'B' group.On the BSE, 8124 shares were traded on the counter so far as against the average daily volumes of 938 shares in the past one month.Powered by Capital Market - Live
Net profit of NGL Fine Chem declined 87.24% to Rs 1.28 crore in the quarter ended December 2024 as against Rs 10.03 crore during the previous quarter ended December 2023. Sales rose 1.31% to Rs 89.10 crore in the quarter ended December 2024 as against Rs 87.95 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales89.1087.95 1 OPM %5.7115.77 - PBDT4.3617.27 -75 PBT1.2714.33 -91 NP1.2810.03 -87 Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live
NGL Fine-Chem will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.54%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.07% to 0.09%
Over the last 5 years, net income has grown at a yearly rate of 15.48%, vs industry avg of 15.29%